Granisetron hydrochloride
CAS: 107007-99-8
Ref. TM-T1042
10mg | 38,00 € | ||
25mg | 56,00 € | ||
50mg | 81,00 € | ||
100mg | 126,00 € | ||
200mg | 176,00 € | ||
500mg | 300,00 € |
Información del producto
- Granisetron HCl
- BRL 43694A
- 1-Methyl-N-(9-Methyl-9-Azabicyclo(3.3.1)Non-3-Yl)-1H-Indazole-3-Carboxamid
- 1-Methyl-N-(9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl)-1H-Indazole-3-Carboxamide
- 1-Methyl-N-(9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl)-1H-Indazole-3-Carboxamide Hydrochloride (1:1)
- 1-Methyl-N-[(3-Endo)-9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl]-1H-Indazole-3-Carboxamide
- 1-Methyl-N-[(3-Endo)-9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl]-1H-Indazole-3-Carboxamide Hydrochloride
- 1H-Indazole-3-Carboxamide, 1-Methyl-N-(9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl)-, Monohydrochloride, Endo-
- 1H-Indazole-3-Carboxamide, 1-Methyl-N-[(3-Endo)-9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl]-, Monohydrochloride
- 1H-Indazole-3-carboxamide, 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-, hydrochloride (1:1)
- Ver más sinónimos
- 9-Azabicyclo[3.3.1]nonane, 1H-indazole-3-carboxamide deriv.
- Brl-43694A
- Brl-43694A, Kytril, 1-Methyl-N-[(3-Endo)-9-Methyl-9-Azabicyclo[3.3.1]Non-3-Yl]-1H-Indazole-3-Carboxamide Hydrochloride
- Endo-1-Methyl-N-(9-Methyl-9-Azabicyclo(3.3.1)Non-3-Yl)-1H-Indazole-3-Carboxa
- Endo-Monohydrochlorid
- Endo-Monohydrochloride
- Granisertrol Hydrochloride
- Granisertronhydrochloride
- Granisetron Hcl
- Granisetron Hydrocholride
- Granisetronhclfda
- Granisetronhydrochloridefdainspected
- Granistron Hydrochloride
- Gransetron Hcl
- Kytril
- Midehydrochloride
Granisetron hydrochloride (Granisetron HCl) is a serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy
Propiedades químicas
Consulta técnica sobre: TM-T1042 Granisetron hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.